WallStreetZenWallStreetZen

NASDAQ: VCNX
Vaccinex Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

VCNX past revenue growth

How has VCNX's revenue growth performed historically?
Company
1,490%
Industry
110.58%
Market
14.02%
VCNX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
VCNX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
VCNX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

VCNX earnings and revenue history

Current Revenue
$795.0k
Current Earnings
-$22.0M
Current Profit Margin
-2,768.8%

VCNX Return on Equity

Current Company
-2,667.3%
Current Industry
15.6%
Current Market
-8.4%
VCNX's Return on Equity (-2,667.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when VCNX announces earnings.

VCNX Return on Assets

Current Company
-475.5%
Current Industry
2.2%
VCNX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

VCNX Return on Capital Employed

Current Company
578.65%
Current Industry
17.7%
VCNX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

VCNX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
VCNX$795.00k-$21.88M-$22.01M+5.10%N/A
NHWK$2.23M-$48.05M-$51.96M-12.53%N/A
ASLN$12.00MN/A-$45.19M+41.42%N/A
ABVC$739.26k-$9.67M-$12.27M+27.36%N/A
SEEL$1.55M-$50.94M-$51.09M+42.59%N/A
View Top Biotech Stocks

Vaccinex Earnings & Revenue FAQ

What were VCNX's earnings last quarter?

On Invalid Date, Vaccinex (NASDAQ: VCNX) reported Q3 2023 earnings per share (EPS) of -$1.09, up 34.73% year over year. Total Vaccinex earnings for the quarter were -$4.91 million. In the same quarter last year, Vaccinex's earnings per share (EPS) was -$1.67.

If you're new to stock investing, here's how to buy Vaccinex stock.

What was VCNX's earnings growth in the past year?

As of Q4 2023, Vaccinex's earnings has grown year over year. Vaccinex's earnings in the past year totalled -$22.01 million.

What was VCNX's revenue last quarter?

On Invalid Date, Vaccinex (NASDAQ: VCNX) reported Q3 2023 revenue of $20.00 thousand up 60% year over year. In the same quarter last year, Vaccinex's revenue was $50.00 thousand.

What was VCNX's revenue growth in the past year?

As of Q4 2023, Vaccinex's revenue has grown 1,490% year over year. This is 1,379.42 percentage points higher than the US Biotechnology industry revenue growth rate of 110.58%. Vaccinex's revenue in the past year totalled $795.00 thousand.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.